The Food and Drug Administration said that a nationwide shortage of Eli Lilly’s Zepbound and Mounjaro ... Law firm Ropes & Gray is staying put in Boston’s Prudential Tower.

Investing in rapidly expanding biotech stocks can be a worthwhile long-term investment. Just one successful drug or device ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...

It cited avocados as an example. Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

Empathy at the Heart, a five-year initiative designed to foster empathy in young children and empower the adults in their lives to support this vital character development Empathy at the Heart is ...

Ro partners with Eli Lilly to offer Zepbound, an FDA-approved obesity treatment, at affordable cash-pay prices through an ...